References
Muller, C. & Rump, A. Nat. Biotechnol. 20, 441–444 (2002).
Hodgson, J. Nat. Biotechnol. 20, 531 (2002).
Workman, P. & Kaye, S.B. Trends Mol. Med. 8 (Suppl), S1–S9 (2002)
von Ghyczy, T., Bassford, C. & von Oetinger, B. (eds). Clausewitz on Strategy: Inspiration and Insight from a Master Strategist (John Wiley & Sons, New York, 2002).
Anonymous. The Economist July 23, 1996, p. 59.
Simon, H. Hidden Champions (Harvard Business School Press, Boston, 1996).
Harvey, A. Drug Disc. Today 5, 294–300 (2000).
Strohl, W.R. Drug Disc. Today 5, 39–41 (2000).
Demain, A.L. Nat. Biotechnol. 20, 331 (2002).
Newman, D.J., Cragg, G.M. & Snader, K.M. Nat. Prod. Rep. 17, 215–234 (2000).
Schreiber, S.L. Science 287, 1964–1969 (2000).
Schreiber, S.L., Nicolaou, K.C. & Davies, K. Chem. Biol. 9, 1–2 (2002).
Acknowledgements
We thank Hiroki Sawa, senior advisor to Medbase and President of Suzuka University of Health Science (Suzuka City, Japan), and Wolfgang Richter of Morphochem (Munich, Germany) for their comments.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fernandes, M., Miska, D. Strategic rethink for German biotechnology. Nat Biotechnol 20, 970–971 (2002). https://doi.org/10.1038/nbt1002-970
Issue Date:
DOI: https://doi.org/10.1038/nbt1002-970
- Springer Nature America, Inc.